Patent · US Active

Anti-cancer therapies

US8318683B2 · kind B2 · utility

0Cited by
4References
17Claims
0Family size

Assignee

Inventor

Key dates

Filing dateFeb 4, 2005
Grant dateNov 27, 2012
Priority date
Expiry dateNov 27, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for the treatment of cancer are described. In particular, methods for treatment of cancer comprising administration of glufosfamide alone or in combination with another anticancer agent are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.